Photorefractive Keratectomy and Corneal Cross-linking in Keratoconus

Evaluation of the safety and efficacy of surface ablation followed by Collagen Cross-linking in patients with keratoconus

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Keratoconus Corneal Diseases Dilatation, Pathologic Eye Diseases Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

contact lens intolerance
corneal thickness > 450 micrometers
Keratometry < 56 diopters
Astigmatism < 6 diopters

Exclusion criteria

corneal thickness < 450 micrometers
Keratometry > 56 diopters
Astigmatism > 6 diopters

Treatment and study plan

Simultaneous Photorefractive Keratectomy and Collagen Cross-linking in patients with keratoconus

Procedure

Photorefractive Keratectomy followed by Collagen Cross-linking in patients with keratoconus in the same surgical setting

Primary outcomes

The change of visual acuity following Photorefractive Keratectomy and Corneal Collagen Cross-linking in patients with Keratoconus

Time frame: 6 months

The change of visual acuity from baseline in patients suffering from keratoconus following treatment with Photorefractive Keratectomy and Corneal Collagen Cross-linking.

Sponsors and collaborators

Lead sponsor

The Eye Center and The Eye Foundation for Research in Ophthalmology

Other

Registry information

Important dates

Study start: 2011
Primary completion: 2013
Study completion: 2013
First posted: Jul 14, 2014
Registry last updated: Jul 14, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed